Business Daily from THE HINDU group of publications
Sunday, Aug 31, 2008
ePaper | Mobile/PDA Version | Audio
News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

 Corporate - Regulatory Bodies & Rulings
Get Latest Quote and Company Info
FDA nod for Dr Reddy's BP drug

Hyderabad, Aug. 30

Pharma Major Dr Reddy's Laboratories Ltd has received approval from the US Food and Drug Administration for its drug, Trandolapril. It is used in the treatment of high blood pressure. The approval facilitates the Hyderabad-based company to market the drug in 1, 2 and 4 mg strengths in the US, according to the information available on its Web site. - Our Bureau

More Stories on : Regulatory Bodies & Rulings | Pharmaceuticals | Dr. Reddy's Laboratories Ltd

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
SpiceJet to seek shareholders’ nod on warrants issue

Stalemate continues in Singur
ONGC may rope in Rosneft as local partner in Imperial Energy
FDA nod for Dr Reddy's BP drug
FACT signs pact with IL&FS
Marico teams up with Coconut Board
Dishman Pharma to invest Rs 500 cr in SEZs
Trigger Apparels plans to go global
ONGC firms up plans for North Tapti offshore field
Audi weighing options for luxury small car launch in India
‘KK Babu’ a doyen who left his own stamp
K.K. Birla passes away




Smartbuy
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line